PTC Provides Update on Translarna™
PTC Provides Update on Translarna™ (ataluren) Application for Label Expansion June 28, 2019 > Original press release < PTC Therapeutics, Inc. announced that the Committee for Medicinal [...]
La Force & Max’s Big Ride in the parliament of Canada
A memorable day Monday, June 10, was the day that closed the loop of the event of Max’s Big Ride to End Duchenne Muscular Dystrophy. La Force & Max’s Big Ride in the parliament of [...]
An international study to learn about your preferences for DMD Treatments
La Force DMD is seeking your participation in a research survey for parents or guardians of sons with Duchenne muscular dystrophy and adult men (18+ years) with Duchenne. This is an international [...]
